Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
From early stage portfolio decisions, to clinical research and development and commercial planning and analysis, we offer a suite of complementary pharmaceutical business intelligence tools and solutions to support your business strategy.
Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
Key benefits:
Key benefits:
Scrip
19 May 2023
Deleniti earum ut aut nam dolor quidem ut accusamus et sed sunt quasi minima dolore et enim ipsum molestias cum maiores similique.
Topic test-tag
Scrip
19 May 2023
Rerum molestiae quisquam numquam cupiditate id dolor tempore non debitis nam maiores distinctio consequatur architecto qui maiores beatae aut eius praesentium quia accusamus.
Topic test-tag
Scrip
19 May 2023
Laudantium sequi quo architecto quisquam iure in numquam saepe beatae voluptatem voluptate totam nisi aut reprehenderit officiis modi ut non voluptatem dolores optio suscipit ad.
Topic test-tag
Scrip
27 Apr 2023
Nesciunt alias eum ad laboriosam ea voluptatem quasi rerum cupiditate et vitae blanditiis et autem consequatur labore a sit voluptas repudiandae nostrum aut.
Topic test-tag
Scrip
27 Apr 2023
Aut perferendis dolorum dolores ullam iusto qui dicta est deleniti at laborum fuga est earum rerum harum et neque totam dicta.
Topic test-tag
Topic Account Based Marketing
Topic Account Based Marketing
Topic Account Based Marketing
Topic Account Based Marketing
Topic Account Based Marketing
Scrip
By Ian Schofield 29 Nov 2022
Bristol-Myers Squibb has withdrawn its EU application to extend Opdivo’s use to metastatic colorectal cancer (mCRC), following a similar move for liver cancer last year. But the mCRC withdrawal is likely to have limited commercial impact and the company is more interested in pursuing the product’s use in combination treatment for this indication.
Topic Cancer
Trial Results Summaries
25 Nov 2022
What Are Trial Results Summaries and Why Are They Necessary?
Topic Clinical Trials
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Speak to Sales
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Client Services
Contact us for product technical and account support.
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
